Cross-Company Abuse Liability Council (CCALC)
Planning the development of CNS-active drugs, including psychedelics?
Dr. Beatrice Setnik will be taking part in several panel discussions and presentations at the upcoming Cross-Company Abuse Liability (CCALC) Meeting. The open forum dialogue includes scientific support and participation by the FDA and will cover the evolving methodological considerations for the preclinical and clinical evaluation of abuse potential and dependence of CNS-active drugs.
Want to meet with Dr. Setnik? You can book time to chat here: https://www.altasciences.com/contact-us?utm_source=linkedin&utm_medium=social&utm_campaign=conference_CCALC_2023
#PsychedelicResearch #LifeSciences #ClinicalTrials